10/131: Deep-brain Stimulation in Obsessive-compulsive Disorder: Randomized, Double-blinded Clinical Trial

Sponsor
Hospital San Carlos, Madrid (Other)
Overall Status
Completed
CT.gov ID
NCT03217123
Collaborator
(none)
7
1
53.9

Study Details

Study Description

Brief Summary

A prospective, randomized, double-blinded study was conducted in 7 OCD patients during which 4 electrode contacts along a striatal axis were stimulated bilaterally. DBS electrode implantation followed a trajectory placing contact zero in nucleus accumbens (a common target for OCD treatment) with more proximal contacts placed in striatal segments defined using projections from prefrontal cortex subdivisions (ventromedial, orbitofrontal, dorsolateral) and anterior cingulate cortex.

Condition or Disease Intervention/Treatment Phase
  • Device: Deep Brain stimulation
N/A

Detailed Description

Patients Seven patients, three men; aged 21-50 years; average (std) 36.67 (±14.64), and four women; aged 28-46 years; average: 35.25 (±8.14), suffering from treatment-refractory obsessive compulsive disorder participated in this study. All patients scored 30 or higher in the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS). They were considered as candidates to DBS for OCD by two independent psychiatrists. An independent psychiatric surgery committee composed of one neurosurgeon, one psychiatrist and one legal medicine expert agreed surgery indication was appropriate. All patients provided written informed consent. The study had approval from the Hospital Clínico San Carlos ethics committee.

Pre-surgical Neuroimaging Before surgery, all patients underwent 3T Siemens TRIO system (Siemens, Erlangen, Germany) MRI scanning. Patients also performed an OCD symptom provocation task during fMRI scanning using modified version of the MOCSS (Maudsley Obsessive-Compulsive Stimuli Set). During scanning, patients were presented with pictures of 4 classes of provocative stimuli, 50 of each type: 1) contamination/washing, 2) checking, 3) hoarding, 4) symmetry/order. The study comprised 4 'blocks' pertaining to the 4 classes of provocative stimuli. Each block consisted of ten 20-s alternating epochs in which subjects viewed either 10 provocative or 10 neutral pictures (see Supplementary material for a full description). Post-operative computed tomography (CT) scanning was used to determine correct electrode positioning.

Neurosurgical procedure The target was selected for the distal electrode contact (contact zero) to be placed at the NAcc close to the bed nucleus of the stria terminalis: 1.5 mm rostral to the anterior border of the anterior commissure, 4 mm ventral to the AC-PC line and 7 mm lateral to the mid-sagittal plane. Then, the striatum was segmented using the deterministic DTI projections of the three subdivisions of the prefrontal cortex (ventromedial vmPFC, orbitofrontal OFC, dorsolateral DLPFC) plus the anterior cingulate cortex (ACC). A trajectory was planned for placing the rest of the contacts of a Medtronic Model 3391 stimulating macroelectrode at several points along the striatum avoiding the ventricles in such a way that each of the electrode contacts (contacts 1, 2, and 3) was closest to each segment of the striatum corresponding to OFC, DLPFC and ACC.

Deep-Brain Stimulation Protocol After surgery, a random sequence of contact activations (0 [Nacc],1,2 and 3), including sham (-), was generated for each patient. Each contact was activated using 130 Hz, 60 ms, and 4.5 V for three months (the sham activation was 0 V) following the patient's individual sequence, separated by one month of washout with the generator turned off

The study meets a double-blind, longitudinal design. Stimulation contact was set following a random series known only by the neurosurgeon, with patient, psychiatry and neuropsychology teams blind. Psychiatric assessment was conducted each month, and neuropsychological testing was performed after each activation and washout period

Symptom-provocation fMRI analysis Functional imaging data were analyzed using statistical parametric mapping (SPM12; http://www.fil.ion.ucl.ac.uk/spm) employing an epoch-related model. The main symptom(s) for each patient was defined and used to construct a contrast of responses to provocation vs. neutral pictures. The ensuing contrasts were masked with an inclusive prefrontal mask and the statistical parametric map thresholded at P < 0.001 uncorrected. Cluster extent was defined using AlphaSIM (threshold P < 0.05). Note that due to weak responses during symptom activation in patients 4 and 6, the SPMs for these patients were first thresholded at P < 0.01 and 0.005 uncorrected, respectively. After the clinical protocol had ended, the projections to the cortical activated areas on the MOCSS for each patient in their main symptomatic dimension from the striatum were calculated using probabilistic tractography. The connectivity between each of the contacts and the fMRI activations was calculated as the number of fibers of the projection of each contact (sphere of diameter 4 mm around the contact) to the cortical activated areas.

Study Design

Study Type:
Interventional
Actual Enrollment :
7 participants
Intervention Model:
Sequential Assignment
Intervention Model Description:
The study meets a double-blind, longitudinal design. Stimulation contact was set following a random series known only by the neurosurgeon, with patient, psychiatry and neuropsychology teams blind. Psychiatric assessment was conducted each month, and neuropsychological testing was performed after each activation and washout periodThe study meets a double-blind, longitudinal design. Stimulation contact was set following a random series known only by the neurosurgeon, with patient, psychiatry and neuropsychology teams blind. Psychiatric assessment was conducted each month, and neuropsychological testing was performed after each activation and washout period
Masking:
Triple (Participant, Care Provider, Investigator)
Masking Description:
Patients were blind to the study phase (contact and parameters of stimulation).
Primary Purpose:
Treatment
Official Title:
Deep-brain Stimulation in Obsessive-compulsive Disorder
Actual Study Start Date :
Jan 1, 2011
Actual Primary Completion Date :
Dec 31, 2014
Actual Study Completion Date :
Jun 30, 2015

Arms and Interventions

Arm Intervention/Treatment
Experimental: Deep Brain stimulation

After the surgery, a random sequence of contact activations (0 [Nacc],1,2 and 3), including sham (-), was generated for each patient. Each contact was activated using 130 Hz, 60 ms, and 4.5 V for three months (the sham activation was 0 V) following the patient's individual sequence, separated by one month of washout with the generator turned off

Device: Deep Brain stimulation
Electrical stimulation at subcortical level
Other Names:
  • Medtronic lead
  • Outcome Measures

    Primary Outcome Measures

    1. Yale-Brown Obsessive-Compulsive Scale [2 years]

      OCD symptoms scale

    Secondary Outcome Measures

    1. Emotion [2 years]

      Depresion and anxiety scores

    Other Outcome Measures

    1. Neuropsychology [2 years]

      Neuropsychological scales (A battery of tests, covering the main cognitive domains, was created to assess neuropsychological changes).

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients suffering from treatment-refractory obsessive compulsive disorder

    • Scored 30 or higher in the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS)

    • Considered as candidates to DBS for OCD by two independent psychiatrists.

    • An independent psychiatric surgery committee composed of one neurosurgeon, one psychiatrist and one legal medicine expert agreed surgery indication was appropriate

    • Provide written informed consent.

    Exclusion Criteria:
    • Any concomitant neurological or psychiatric condition

    • Any surgical contraindication

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Hospital San Carlos, Madrid

    Investigators

    • Principal Investigator: Juan A Barcia, MD PhD, Hospital San Carlos

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Juan Antonio Barcia Albacar, Head of Neurosurgery Department, Hospital San Carlos, Madrid
    ClinicalTrials.gov Identifier:
    NCT03217123
    Other Study ID Numbers:
    • 10/131
    First Posted:
    Jul 13, 2017
    Last Update Posted:
    Jul 18, 2017
    Last Verified:
    Jul 1, 2017
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Juan Antonio Barcia Albacar, Head of Neurosurgery Department, Hospital San Carlos, Madrid
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 18, 2017